by Jim Thompson | Mar 12, 2013 | Advocacy, Antiretrovirals, CROI, CROI 2013, Funding, Genetics, Prevention, Research, Spanish, Treatment as Prevention |
Julio Montaner, MD is the Director of the British Columbia Centre for Excellence in HIV/AIDS and Director of IDC and Physician Program Director for HIV/AIDS PHC. Rob Camp is a member of ATAC and a long-standing and invaluable voice in the advocacy community. Dr....
by Jim Thompson | Mar 9, 2013 | Advocacy, African Americans, Aging, Antiretrovirals, Blog, Co-infection, Co-morbidities, CONFERENCES, CROI, CROI 2013, Cure, Funding, Genetics, Global, Hepatitis, Metabolics, Microbicides, Pacific NW, Pediatrics, Prevention, Research, Toxicity, Treatment as Prevention, Tuberculosis, Vaccine, Women |
Dr. Kevin De Cock, Chair of the 20th CROI, introduces IFARA’s CROI Treatment Update Series. Each year IFARA (AccessHIV) conducts 40 Interviews and Panels at the Conference on RetroViruses and Opportunistic Infections as part of the Treatment Update – some...
by Jim Thompson | Mar 9, 2013 | Aging, Blog, CROI, CROI 2013, Cure, Genetics, Toxicity, Vaccine |
Ronald Mitsuyasu, MD is a practicing physician, specializing in Oncology and Hematology. Dr. Mitsuyasu is also Director, of the CARE Center, Professor in Residence, Department of Medicine, Hematology/Oncology at UCLA, Associate Director for Clinical Programs, UCLA...
by Jim Thompson | Mar 7, 2013 | Antiretrovirals, CROI, CROI 2013, Cure, Genetics, Research |
John Coffin, PhD is Professor of Molecular Biology & Microbiology at Tufts University. Dr. Coffin’s research focuses on microbiological interaction between retroviral and host cells. In this interview Dr. Coffin discusses his research and provides a broader...
